Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Pharmaron(300759) the Revenue is 4.017 B (+20.19%), Beat estimate;the EBIT is 513.87 M (+12.17%), Miss estimate;the EPS is 0.226 (+0.8%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
4.02B20.19%
3.98B19.11%
+0.04B1.08%
EBITMiss expectations
0.51B12.17%
0.52B13.33%
-0.01B1.16%
EPSMiss expectations
0.22630.80%
0.246.90%
-0.01376.10%
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf